Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation
2018 · EMBO Reports · 67 citations
https://doi.org/10.15252/embr.201744767
Y
Yongxian Zhuang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.3K
Citations
14
h-index
20
i10-index
Yongxian Zhuang is an academic researcher from Revolution Medicines (United States). The author has contributed to research in topics: Metabolism, Diabetes, and Cancer & Cancer, Hypoxia, and Metabolism & Pancreatic function and diabetes. The author has an h-index of 14, co-authored 37 publications.
ORCID: 0000-0001-8219-7764Papers by this author
worksThe novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer
2019 · Cancer & Metabolism · 21 citations
https://doi.org/10.1186/s40170-018-0193-4
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
2022 · Molecular Therapy — Oncolytics · 14 citations
https://doi.org/10.1016/j.omto.2022.11.002
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
2021 · npj Breast Cancer · 11 citations
https://doi.org/10.1038/s41523-021-00285-x
Metadata record for the manuscript: Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
2021 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.14035853
Replacement of glucose with fructose or galactose does not prevent metformin induced cell death or metformin induced ATP reduction.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0108444.g006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat